169 related articles for article (PubMed ID: 3133317)
41. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase.
Obernesser HJ; Döring G
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):248-56. PubMed ID: 6812322
[TBL] [Abstract][Full Text] [Related]
42. Polyamine biosynthesis is necessary for interleukin-2-dependent proliferation but not for interleukin-2 production or high-affinity interleukin-2 receptor expression.
Yukioka K; Otani S; Matsui-Yuasa I; Shibata T; Nishizawa Y; Morii H; Morisawa S
J Biochem; 1987 Dec; 102(6):1469-76. PubMed ID: 3129415
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
Santoli D; Zurier RB
J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
[TBL] [Abstract][Full Text] [Related]
44. Binding of phycoerythrin-conjugated interleukin-6 to in vitro-activated human peripheral blood mononuclear cells--effect of immunosuppressive agents and of a calcium channel blocker.
Degiannis D; Luke-Gustites D; Mikhail N; Raska K; Raskova J
Transplantation; 1992 Aug; 54(2):308-12. PubMed ID: 1496542
[TBL] [Abstract][Full Text] [Related]
45. Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers.
Khalfoun B; Thibault G; Lacord M; Gruel Y; Bardos P; Lebranchu Y
Scand J Immunol; 1996 Mar; 43(3):248-56. PubMed ID: 8602457
[TBL] [Abstract][Full Text] [Related]
46. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.
Steuhl KP; Döring G; Henni A; Thiel HJ; Botzenhart K
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411
[TBL] [Abstract][Full Text] [Related]
47. Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.
Johnson DA; Carter-Hamm B; Dralle WM
Am Rev Respir Dis; 1982 Dec; 126(6):1070-3. PubMed ID: 6817677
[TBL] [Abstract][Full Text] [Related]
48. Evidence that 8-methoxypsoralen (8-MOP) is a T-lymphocyte immunomodulatory agent.
Cox GW; Orosz CG; Lewis MG; Olsen RG; Fertel RH
Int J Immunopharmacol; 1988; 10(6):773-81. PubMed ID: 3264275
[TBL] [Abstract][Full Text] [Related]
49. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis.
Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A
Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796
[TBL] [Abstract][Full Text] [Related]
50. Mechanism whereby ouabain inhibits human T lymphocyte activation: effect on the interleukin 2 pathway.
Dornand J; Favero J; Bonnafous JC; Mani JC
Immunobiology; 1986 Jul; 171(4-5):436-50. PubMed ID: 3091487
[TBL] [Abstract][Full Text] [Related]
51. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.
Grabstein K; Dower S; Gillis S; Urdal D; Larsen A
J Immunol; 1986 Jun; 136(12):4503-8. PubMed ID: 3086434
[TBL] [Abstract][Full Text] [Related]
52. Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected].
Kuhweide R; Van Damme J; Lorre K; Baroja ML; Tsudo M; Ceuppens JL
Cytokine; 1990 Jan; 2(1):45-54. PubMed ID: 2104213
[TBL] [Abstract][Full Text] [Related]
53. Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases.
Caballero AR; Moreau JM; Engel LS; Marquart ME; Hill JM; O'Callaghan RJ
Anal Biochem; 2001 Mar; 290(2):330-7. PubMed ID: 11237336
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa.
Kharazmi A
Immunol Lett; 1991 Oct; 30(2):201-5. PubMed ID: 1757106
[TBL] [Abstract][Full Text] [Related]
55. Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.
Horst HJ; Flad HD
Clin Exp Immunol; 1987 Apr; 68(1):156-61. PubMed ID: 3115640
[TBL] [Abstract][Full Text] [Related]
56. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
[TBL] [Abstract][Full Text] [Related]
57. [Study of the action and production of interleukin 2 (IL 2), expression of the IL 2 receptor and characterization of the immunologic phenotype of lymphocytes in the peripheral blood and lymph nodes of 51 patients with cancer of the larynx].
Proto E; Coiana A; Macciò A; Manduco D; Mantovani G
Acta Otorhinolaryngol Ital; 1987; 7(5):457-74. PubMed ID: 3126622
[No Abstract] [Full Text] [Related]
58. Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects.
Cossarizza A; Monti D; Bersani F; Paganelli R; Montagnani G; Cadossi R; Cantini M; Franceschi C
FEBS Lett; 1989 May; 248(1-2):141-4. PubMed ID: 2785933
[TBL] [Abstract][Full Text] [Related]
59. Stimulation of secretion into human and feline airways by Pseudomonas aeruginosa proteases.
Somerville M; Richardson PS; Rutman A; Wilson R; Cole PJ
J Appl Physiol (1985); 1991 May; 70(5):2259-67. PubMed ID: 1907606
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes.
Ulmer AJ; Pryjma J; Tarnok Z; Ernst M; Flad HD
Infect Immun; 1990 Mar; 58(3):808-15. PubMed ID: 2106495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
